Increased Funding for Rare Disease Research: A Critical Need

Rare diseases, also known as orphan diseases, affect approximately 300 million people worldwide. Despite the large number of patients collectively, each specific rare disease affects fewer than 200,000 people, often making research into these conditions underfunded and overlooked. There are more than 7,000 rare diseases, many of which are life-threatening and have no known cure. Unfortunately, due to the low prevalence of individual conditions, rare diseases receive only a fraction of the research funding allocated to more common illnesses.

 

Global Toll of Rare Diseases: Thousands of Lives Lost Annually

1. Approximately 300 million people globally are affected by rare diseases, which number between 6,000 and 8,000 distinct conditions. While specific data on annual deaths from rare diseases is limited, it's estimated that 30% of children with rare diseases die before the age of 5. Rare diseases contribute significantly to mortality, often because many are life-threatening or chronic conditions.

 

2. In Europe, for instance, rare diseases account for about 1 in 3 deaths in children under 1 year. The lack of treatments for most of these diseases, along with their complexity, makes it challenging to compile accurate annual death figures. However, considering the overall burden, tens of thousands of deaths per year are likely attributable to rare diseases globally.

 

Why increased funding matters

1. Delayed Diagnosis: On average, rare disease patients wait 5-7 years for a diagnosis. More funding can improve diagnostic tools and healthcare training.

2. Limited Treatments: Most rare diseases lack effective treatments, including deadly forms of Crohn’s disease, which have no cure. Research funding can explore new therapies and offer hope to patients like those affected by severe Crohn’s.

3. Impact on Families: Rare diseases affect entire families, and funding can improve quality of life by advancing treatments that manage symptoms and slow disease progression.

 

Call to action

Increased research funding can lead to medical breakthroughs that benefit both rare disease patients and the wider medical community. Families facing conditions like severe Crohn’s disease depend on these advancements. Every life matters—investing in rare disease research is essential for hope and future cures.